Pfizer is also making strides in the weight management market. It now owns one of the more promising mid-stage assets in this ...

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

This allows brands to develop breakthrough hair serums more quickly and more consistently across global markets. Industry ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

India, Jan. 23 -- This mid-cap Pharma stock, engaged in developing and manufacturing APIs, formulations, and biotech products ...

Sai Parenteral Limited and Hella Infra Market have received final approval for their IPOs from Sebi. Sai Parenteral's ...

A potential inflection point that Bausch Health hoped could diversify its portfolio has vanished with a pair of phase 3 failures for a new formulation of the company’s bread-and-butter Xifaxan—a ...

New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of ...

Initiation of phase 1 portion of the trial planned in 2H 2026-Phase 2 portion of the trial will initiate development of the elraglusib tablet in ...

Stability is a critical factor in drug formulation, with implications for product quality, lifecycle management, and ...

GreenWay Tanasi, LLC, the consumer wellness company behind the Tanasi(TM) brand, today announced that the proprietary 1:1 cannabidiol (CBD) and cannabidiolic acid (CBDA) formulation used across its ...